Skip to main content
Clinical Trials/NCT04616651
NCT04616651TerminatedNot Applicable

Patient-centered Development of the Cancer Support Community's Open to Options ®Chatbot Program Cancer Treatment Support in Partnership With the Cancer Support Community

University of Michigan Rogel Cancer Center1 site in 1 country18 target enrollmentStarted: March 25, 2021Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Terminated
Enrollment
18
Locations
1
Primary Endpoint
Feasibility of Integrating Chatbot in Clinic

Study Overview

Brief Summary

This study is designed to study the feasibility and acceptability of the Open to Options (O2O) Chatbot prototype. The O2O program is an existing patient support program with content currently delivered via in-person counseling with a trained mental health professional or via an existing web-based program (Let's Talk Treatment Options).The Chatbot is an automated, menu-based agent being developed in this study to extend the reach and accessibility of the O2O program via the Chatbot's "virtual coaching".

Detailed Description

This is a pilot study to assess feasibility and acceptability, and to gather preliminary data on how patients with a diagnosis of cancer appraise being prepared for their upcoming visit with a cancer specialist. Participants will be randomized to take a survey either before or after their Chatbot interaction. The surveys collect participants' self-appraisal regarding preparedness for their upcoming appointment with a cancer physician, cancer distress and cancer anxiety. The study will examine whether patients who take the survey after viewing the Chatbot feel more prepared for their upcoming appointment than those who take the survey before the Chatbot interaction.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Health Services Research
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Patients with a cancer diagnosis
  • •Able to speak and read English, and willing to electronically consent
  • •Appointment with a Rogel Cancer Center cancer clinician within the next 3 weeks
  • •Patient must have a way to access the internet (includes mobile phone)

Exclusion Criteria

  • •Age <18 years
  • •Inability to speak or read English
  • •Inability to give informed consent

Arms & Interventions

Pre-Chatbot survey arm

Active Comparator

Participants will take the self-appraisal survey prior to interacting with the O2O program via the online Chatbot.

Intervention: Online Survey (Behavioral)

Pre-Chatbot survey arm

Active Comparator

Participants will take the self-appraisal survey prior to interacting with the O2O program via the online Chatbot.

Intervention: Chatbot prototype (Behavioral)

Pre-Chatbot survey arm

Active Comparator

Participants will take the self-appraisal survey prior to interacting with the O2O program via the online Chatbot.

Intervention: Open to Options (O2O) Program (Behavioral)

Post-Chatbot survey arm

Experimental

Participants will take the self-appraisal survey after interacting with the O2O program via the online Chatbot. (This arm will also answer additional questions regarding participants' satisfaction with the O2O Chatbot.)

Intervention: Online Survey (Behavioral)

Post-Chatbot survey arm

Experimental

Participants will take the self-appraisal survey after interacting with the O2O program via the online Chatbot. (This arm will also answer additional questions regarding participants' satisfaction with the O2O Chatbot.)

Intervention: Chatbot prototype (Behavioral)

Post-Chatbot survey arm

Experimental

Participants will take the self-appraisal survey after interacting with the O2O program via the online Chatbot. (This arm will also answer additional questions regarding participants' satisfaction with the O2O Chatbot.)

Intervention: Open to Options (O2O) Program (Behavioral)

Outcomes

Primary Outcomes

Feasibility of Integrating Chatbot in Clinic

Time Frame: At the time of scheduling an appointment with cancer physician; one day

The feasibility of integrating an Open to Options (O2O) Chatbot into the clinical workflow, assessed by the number of patients who accept the invitation to receive more information about the study, among all those invited.

Acceptability - Reach

Time Frame: Baseline (Before appointment with cancer physician); up to approximately 3 weeks after scheduling appointment

Assessed by the number of patients who log-in to the O2O Chatbot program and create an account, among all those who accepted the invitation to receive information.

Acceptability - Uptake

Time Frame: Baseline (Before appointment with cancer physician); up to approximately 3 weeks after scheduling appointment

Assessed by the number of patients who proceed to view the full Chatbot prototype and generate a summary, among all those who created an account.

Acceptability - Mean Satisfaction Scores

Time Frame: Baseline (Before appointment with cancer physician); up to approximately 3 weeks after scheduling appointment

Post-Intervention Survey Group only: In addition to the survey given to all participants, the post-intervention survey group will answer 6 questions about their perception of the Chatbot prototype. Each of the 6 questions will be scored on a scale from 1 (strongly disagree) to 5 (strongly agree). Investigators will calculate the mean value (and Standard Deviation) on a 1-5 scale for each question.

Acceptability - Percent of Participants with High Satisfaction Scores

Time Frame: Baseline (Before appointment with cancer physician); up to approximately 3 weeks after scheduling appointment

Post-Intervention Survey Group only: In addition to the survey given to all participants, the post-intervention survey group will answer 6 questions about their perception of the Chatbot prototype. Each of the 6 questions will be scored on a scale from 1 (strongly disagree) to 5 (strongly agree). For each of the six questions, investigators will calculate the percentage of participants who strongly agree.

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials